In support of this, the expressions of TNFRSF14, CD160, and KLRK1 were all strongly positively correlated with the IL2NK phenotype compared with other immune cell phenotypes in BLCA tumors. This evidence concerns the gene TNFRSF14 and bladder transitional cell carcinoma.